Associated Papers
Genetic disease risks of under-represented founder populations in New York City.
Isshiki M et al.
Plos Genetics, 2025
40554605 (PubMed )
Supplement: pgen.1011755.s006.xlsx › TableS2
Genetic disease risks of under-represented founder populations in New York City.
Isshiki M et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
39399040 (PubMed )
Supplement: media-1.xlsx › TableS2
Expanding the clinical phenotype and genetic spectrum of GEMIN5 disorders: Early-infantile developmental and epileptic encephalopathies.
Zhang J et al.
Brain and Behavior, 2024
Novel compound heterozygous mutation and phenotype in the tetratricopeptide repeat-like domain of the GEMIN5 gene in two Chinese families.
Zhang X et al.
Journal of Human Genetics, 2023
A Biallelic Truncating Variant in the TPR Domain of GEMIN5 Associated with Intellectual Disability and Cerebral Atrophy.
Ibrahim N et al.
Genes, 2023
36980979 (PubMed )
Supplement: genes-14-00707-s001.zip › Table_S2.xlsx › Sheet1
Structural basis for Gemin5 decamer-mediated mRNA binding.
Guo Q et al.
Nature Communications, 2022
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder.
Kour S et al.
Nature Communications, 2021
Select a paper to view details